News-Medical.Net on MSN
Researchers identify possible target for new therapies against periodontitis aggravated by smoking
Smoking tobacco is known to worsen symptoms of periodontitis and reduce responsiveness to treatment. Using high-resolution ...
The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.
Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...
Smoking tobacco is known to worsen symptoms of periodontitis and reduce responsiveness to treatment. Using high-resolution ...
Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.
Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...
2hon MSN
Autologous T cell therapy targeting multiple antigens shows promise in treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Engineers at the University of California have developed a new data structure and compression technique that enables the ...
Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in ...
Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.
Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...
The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results